Back to results
US 10,377,758 B2Granted
Co-crystals of ibrutinib with carboxylic acids
Assigneeratiopharm GmbH
InventorsWolfgang Albrecht, Jens Geier, Sebastian Rabe, David Perez Palacios
Life of this patent
Estimating the term…
Abstract
The present invention relates to co-crystals of ibrutinib, a pharmaceutical composition comprising the same as well as a method of preparing the same.
Claims4
A co-crystal of ibrutinib and fumaric acid, wherein said ibrutinib fumatic acid co-crystal has characteristic X-ray power diffraction peaks at 9.9, 17.4, 18.7, 20.5 and 21.7 degrees 2-theta±0.2 degrees 2-theta.
Dependencies are inferred from the claim text.